We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VISN
1676
Vistance Networks Inc
VISN
$1.55B
| $45.6K | ﹤0.01% |
8,100
-177,760
| -96% | -$850K |
|
|
AGEN
1677
Agenus
AGEN
$323M
| $45.1K | ﹤0.01% |
1,409
+826
| +142% | +$26.4K |
|
1678
CorVel
CRVL
$3.62B
| $45.1K | ﹤0.01% |
699
-897
| -56% | -$60K |
|
1679
First Citizens BancShares
FCNCA
$24.4B
| $44.9K | ﹤0.01% |
+35
| New | +$40.5K |
|
|
NEX
1680
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $44.7K | ﹤0.01% |
5,000
-67,925
| -93% | -$560K |
|
1681
Lyell Immunopharma
LYEL
$267M
| $44K | ﹤0.01% |
+692
| New | +$38.3K |
|
1682
Northeast Bank
NBN
$1.15B
| $43.9K | ﹤0.01% |
1,053
| – | – |
|
1683
Regenxbio
RGNX
$525M
| $43.9K | ﹤0.01% |
2,195
-1,921
| -47% | -$37K |
|
1684
ImmunityBio
IBRX
$8.63B
| $43.8K | ﹤0.01% |
15,755
-6,252
| -28% | -$17.7K |
|
|
STEL
1685
DELISTED
Stellar Bancorp
STEL
| $43.1K | ﹤0.01% |
1,881
+1,555
| +477% | +$36.2K |
|
1686
Deluxe
DLX
$1.08B
| $43K | ﹤0.01% |
2,459
-138
| -5% | -$2.17K |
|
|
TWKS
1687
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $42.9K | ﹤0.01% |
+5,681
| New | +$42K |
|
1688
Viatris
VTRS
$19.1B
| $42.8K | ﹤0.01% |
4,286
-9,157,966
| -100% | -$87.5M |
|
1689
Greif Class B
GEF.B
$4B
| $42.7K | ﹤0.01% |
553
-588
| -52% | -$44.8K |
|
1690
Packaging Corp of America
PKG
$20.6B
| $42.4K | ﹤0.01% |
+321
| New | +$42.9K |
|
|
FPI
1691
Farmland Partners
FPI
$468M
| $41.8K | ﹤0.01% |
3,420
-2,993
| -47% | -$33.5K |
|
1692
CONMED
CNMD
$1.41B
| $41.4K | ﹤0.01% |
+305
| New | +$37.2K |
|
1693
Mitsubishi UFJ Financial
MUFG
$267B
| $40.3K | ﹤0.01% |
5,473
+68
| +1% | +$453 |
|
1694
CRA International
CRAI
$1.04B
| $40.3K | ﹤0.01% |
395
-347
| -47% | -$35K |
|
1695
Helmerich & Payne
HP
$4.34B
| $40.3K | ﹤0.01% |
1,136
-1,328
| -54% | -$45.3K |
|
1696
Capital City Bank Group
CCBG
$866M
| $40K | ﹤0.01% |
1,306
+28
| +2% | +$846 |
|
1697
Beazer Homes USA
BZH
$890M
| $40K | ﹤0.01% |
1,414
+65
| +5% | +$1.32K |
|
1698
Employers Holdings
EIG
$896M
| $39.4K | ﹤0.01% |
1,052
+130
| +14% | +$5.09K |
|
1699
Loews
L
$22.3B
| $38.8K | ﹤0.01% |
654
-62
| -9% | -$3.59K |
|
1700
Green Brick Partners
GRBK
$2.89B
| $38.7K | ﹤0.01% |
682
-910
| -57% | -$42.4K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.